Diagnoses prior to surgery included invasive ductal carcinoma (n = 8, 72.7%), ductal carcinoma in situ (n = 2, 18.2%), and genetic risk from a BRCA1 gene mutation with family history of breast cancer (n = 1, 9.1%) (Figure 1). Here, BRCA1 is linked to invasive ductal breast carcinoma.